These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines. Mevissen ML, Kwekkeboom J, Goormachtig E, Lindhout E, de Groot C. Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Yokoi T, Miyawaki T, Yachie A, Kato K, Kasahara Y, Taniguchi N. Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322 [Abstract] [Full Text] [Related]
4. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines. Ifversen P, Zhang XM, Ohlin M, Zeuthen J, Borrebaeck CA. Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232 [Abstract] [Full Text] [Related]
5. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus. Blazar BA, Sutton LM, Strome M. Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371 [Abstract] [Full Text] [Related]
9. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines. Jochems GJ, Klein MR, Jordens R, Pascual-Salcedo D, van Boxtel-Oosterhof F, van Lier RA, Zeijlemaker WP. Hum Antibodies Hybridomas; 1991 Apr; 2(2):57-64. PubMed ID: 1651786 [Abstract] [Full Text] [Related]
11. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2. Tseng CT, Springgate CF, Piela TH, Choi YS. J Immunol; 1987 Apr 15; 138(8):2554-60. PubMed ID: 3031160 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus-transformed B lymphocytes produce low molecular mass molecules with autocrine growth factor and competence factor activity. Garzelli C, Bazzichi A, Dayah AM, Manunta M, Incaprera M, Falcone G. FEMS Microbiol Lett; 1992 Dec 15; 100(1-3):449-54. PubMed ID: 1335948 [Abstract] [Full Text] [Related]
13. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells. Buck J, Hämmerling U, Hoffmann MK, Levi E, Welte K. J Immunol; 1987 May 01; 138(9):2923-8. PubMed ID: 3033079 [Abstract] [Full Text] [Related]
14. Autocrine production of pre-B-cell stimulating activity by a variety of transformed murine pre-B-cell lines. Lemoine FM, Krystal G, Humphries RK, Eaves CJ. Cancer Res; 1988 Nov 15; 48(22):6438-43. PubMed ID: 3263188 [Abstract] [Full Text] [Related]
15. Autocrine models of B-lymphocyte growth. II. Interleukin-1 supports the proliferation of transformed lymphoblasts but not the stimulation of resting B cells triggered through their receptors for antigen. Gordon J, Guy G, Walker L. Immunology; 1986 Mar 15; 57(3):419-23. PubMed ID: 3007333 [Abstract] [Full Text] [Related]
16. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes. Muraguchi A, Nishimoto H, Kawamura N, Hori A, Kishimoto T. J Immunol; 1986 Jul 01; 137(1):179-86. PubMed ID: 3486912 [Abstract] [Full Text] [Related]
17. Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line. Scala G, Morrone G, Tamburrini M, Alfinito F, Pastore CI, D'Alessio G, Venuta S. J Immunol; 1987 Apr 15; 138(8):2527-34. PubMed ID: 2435800 [Abstract] [Full Text] [Related]
18. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6. Tosato G, Gerrard TL, Goldman NG, Pike SE. J Immunol; 1988 Jun 15; 140(12):4329-36. PubMed ID: 2836512 [Abstract] [Full Text] [Related]
19. The role of lactic acid in autocrine B-cell growth stimulation. Pike SE, Markey SP, Ijames C, Jones KD, Tosato G. Proc Natl Acad Sci U S A; 1991 Dec 15; 88(24):11081-5. PubMed ID: 1662382 [Abstract] [Full Text] [Related]
20. Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities. Tiebout RF, Sauerwein RW, van der Meer WG, van Boxtel-Oosterhof F, Zeijlemaker WP. Immunology; 1987 Feb 15; 60(2):187-93. PubMed ID: 3028938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]